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Abstract
Background & Aims—Chronic unexplained nausea and vomiting (CUNV) is a debilitating 
disease of unknown cause. Symptoms of CUNV substantially overlap with those of gastroparesis, 
so the diseases therefore may share pathophysiologic features. We investigated this hypothesis by 
quantifying densities of interstitial cells of Cajal (ICCs) and mapping slow wave abnormalities in 
patients with CUNV vs controls.
Methods—Clinical data and gastric biopsy specimens were collected from 9 consecutive patients 
with at least 6 months of continuous symptoms of CUNV, but normal gastric emptying, treated at 
the University of Mississippi Medical Center, and from 9 controls (individuals undergoing 
bariatric surgery but free of gastrointestinal disease or diabetes). ICCs were counted and 
ultrastructural analyses were performed on tissue samples. Slow-wave propagation profiles were 
defined by high-resolution electrical mapping (256 electrodes; 36 cm2). Results from patients with 
CUNV were compared to those of controls as well as patients with gastroparesis who were 
previously studied by identical methods.
Results—Patients with CUNV had fewer ICCs than controls (mean 3.5 vs 5.6 bodies/field; P<.
05), with mild ultrastructural abnormalities in the remaining ICCs. Slow-wave dysrhythmias were 
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identified in all 9 subjects with CUNV vs only 1/9 controls. Dysrhythmias included abnormalities 
of initiation (stable ectopic pacemakers, unstable focal activities) and conduction (retrograde 
propagation, wave front collisions, conduction blocks, and re-entry), operating across 
bradygastric, normal (range 2.4−3.7 cycles/min), and tachygastric frequencies; dysrhythmias 
showed velocity anisotropy (mean 3.3 mm/s longitudinal vs 7.6 mm/s circumferential, P<.01). 
ICCs were less depleted in patients with CUNV than those with gastroparesis (mean 3.5 vs 2.3 
bodies/field; P<.05), but slow-wave dysrhythmias were similar between groups.
Conclusions—This study defined cellular and bioelectrical abnormalities in patients with 
CUNV, including the identification of slow-wave re-entry. Pathophysiologic features of CUNV 
were observed to be similar to those of gastroparesis, indicating that they could be spectra of the 
same disorder. These findings offer new insights into the pathogenesis of CUNV and may help to 
inform future treatments.
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INTRODUCTION
Chronic unexplained nausea and vomiting (CUNV) is a relatively uncommon but 
debilitating disease. The cause is currently unknown, with patients exhibiting chronic gastric 
symptoms while demonstrating normal gastric emptying and lacking obstruction or obvious 
structural abnormality.1,2
Pasricha et al. recently comprehensively reported the clinical features of CUNV.2 It was 
found that the features of this disorder overlap substantially with gastroparesis, being almost 
identical in terms of demographics, symptoms, disease duration, health care utilization, and 
quality of life. Similar observations have also been reported elsewhere.3,4 Pasricha et al. 
concluded that CUNV is poorly defined and not adequately categorized by Rome III criteria, 
and that further research was needed to determine whether CUNV is part of a spectrum of 
the same syndrome as gastroparesis, or represents a distinct disorder(s).2
There has been substantial recent progress in understanding the pathogenic mechanisms of 
gastroparesis,5,6 and among several contributing factors, there is an increasing focus on the 
role played by interstitial cells of Cajal (ICC). ICC depletion is now recognized as the 
predominant cellular abnormality in gastroparesis.7–9 By contrast, few studies to date have 
investigated the mechanisms underlying CUNV,10 and a role for ICC has not been 
adequately evaluated.
ICC generate and propagate slow waves, which coordinate phasic gastric contractions, and 
ICC loss in gastroparesis is known to be associated with dysrhythmic slow wave activity.9,11 
In particular, a recent study, using new techniques of high-resolution (HR), multi-electrode 
mapping,12 demonstrated a range of abnormal slow wave initiation and conduction patterns 
in most patients with gastroparesis, which were not observed in controls.9 Gastric 
dysrhythmias are associated with nausea and vomiting, potentially causing these symptoms, 
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and could therefore be contributing to the pathophysiology and symptomatology of both 
CUNV and gastroparesis.13,14
In this study, we hypothesized that ICC depletion and spatially-complex slow wave 
dysrhythmias occur in CUNV, as has been found in gastroparesis. This hypothesis was 
tested by performing ICC density and ultrastructural analyses, in combination with in-vivo 
HR gastric mapping in a cohort of CUNV patients, with comparison to new controls and 
gastroparetic patients previously investigated using identical methods.
METHODS
Ethical approval was granted by the New Zealand Regional Ethics Committee, and by the 
Institutional Review Boards at The University of Mississippi and Mayo Clinic. All patients 
provided informed consent.
Patients
CUNV Cohort: Consecutive patients with at least six months of continuous symptoms of 
CUNV who were undergoing implantation of gastric electrical stimulation devices at the 
University of Mississippi Medical Center were invited to participate. All patients had a 
history, drug history, physical examination, upper endoscopy, and appropriate radiological 
and laboratory investigations to exclude other causes of symptoms. Patients with cyclic 
vomiting syndrome were excluded.15 Patients were also excluded if they had gastroparesis, 
as diagnosed by scintigraphy testing according to a standardized test meal16 and consensus 
recommendations (>60% retention at 2 hours and / or >10% gastric retention at 4 hours),2,17 
or malignancy, primary eating disorders, or pregnancy. Hyperglycemia can induce 
dysrhythmias,18 and blood glucose was kept within the normal range during the 
perioperative period.
Demographic data, comorbidities, medical histories, and body mass index were recorded. 
Total symptom scores were calculated by scoring five symptoms (pain, bloating / distension, 
nausea, vomiting, and early satiety) on a five-point scale (0, absent; 4, severe).9
ICC Controls were age-matched patients undergoing bariatric surgery, who were free of 
gastrointestinal diseases or diabetes. Obesity does not affect ICC numbers,7 but age 
matching was performed because ICC decrease by approximately 13% per decade.19
HR mapping controls were patients undergoing elective upper-abdominal surgery. Patients 
were excluded if they had previous gastric surgery, known gastric pathology, or a condition 
in which dysrhythmic gastric activity has been described, including gastroparesis, gastric 
tumors, pregnancy, anorexia nervosa, functional dyspepsia, atrophic gastritis, or hypo- or 
hyperthyroidism.13,20 Control patients were not taking gastric prokinetics or medications 
affecting gastric electrical activity.
A historical cohort of gastroparetic patients was utilized for further comparison.9 These 
patients underwent HR gastric mapping and ICC density analysis using identical methods, at 
the same institutions.
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ICC Density and Ultrastructural Analysis
Full-thickness gastric biopsy specimens were collected from the anterior stomach, midway 
between the curvatures and approximately 9 cm proximal to the pylorus. This site is the 
same as that chosen by the Gastroparesis Clinical Research Consortium (GpCRC) in their 
studies of cellular defects in gastroparesis.7,8 ICC cell bodies in the circular muscle layer 
were identified using a Kit antibody (mouse 1:400; Lab Vision MS-482-P; Thermo Fisher 
Scientific, Waltham, MA) and a 4-,6-diamidino-2-phenylindole (DAPI) nucleus 
counterstain, where co-localization of a DAPI-positive nucleus within a Kit-positive ICC 
signified an ICC cell body. Using the methods described by Grover et al7,21 ICC density 
was calculated by quantifying the number of cell bodies per field across 20 high-powered 
fields per specimen. Electron microscopy studies of ICC were also performed on CUNV and 
control tissues using previously described methodology.8
High-Resolution Electrical Mapping
HR mapping was performed using established and validated extracellular methods.9,22,23 
Flexible printed circuit board (PCB) electrode arrays were used (96–256 electrodes; 4–5.2 
mm interelectrode spacing; Figure 1A).24 All recordings were performed intraoperatively 
after general anesthesia and laparotomy (Table 1). These anesthetic conditions are not 
known to affect slow waves,22,25 except for the use of opiates, which may be associated 
with myoelectrical abnormalities.26
Mapping was undertaken before organ handling or stimulator placement. The PCBs were 
laid on the anterior serosa with reference to gastric landmarks.22 Warm saline-soaked gauze 
was overlain, and the cables were allowed to move freely with respiration. Patients were 
mapped for up to 15 minutes, over 1–3 gastric regions. Reference electrodes were placed on 
the shoulders and unipolar signals were acquired at 512 Hz using an ActiveTwo System 
(Biosemi, The Netherlands) modified for passive recordings.
Signal Processing, Analysis, and Interpretation
HR mapping data was analyzed in the Gastrointestinal Electrical Mapping Suite (GEMS), v.
1.5.27 Recordings were down-sampled (30 Hz) and filtered with moving-median and 
Savitzky-Golay filters.28 Slow wave activation times were identified using the FEVT 
algorithm,29 and were clustered into cycles using the REGROUPS algorithm,30 with manual 
correction. Activation maps were calculated (e.g., Figure 1),30 and sites of conduction block 
were identified. Slow wave propagation animations were generated.27
Frequency was calculated by averaging the cycle-to-cycle intervals between activation 
times. The normal human gastric slow wave frequency was defined as 2.4 – 3.7 cycles/min 
based on electrogastrography literature.31 Velocity was calculated using a finite difference 
method with Gaussian-smoothing filter, and visualized using directional arrows on a color-
gradient speed map.32 In addition, velocity was secondarily averaged across regions of 
circumferential and longitudinal propagation, to investigate conduction anisotropy.33 
Amplitudes were calculated by applying a peak-to-trough detection algorithm.28
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All data were screened for dysrhythmias by isochronal mapping and animation.27 
Dysrhythmias were identified, defined, and quantified by frequency, rhythm (stable vs 
unstable), and spatial pattern (abnormalities of initiation and/or conduction), using 
established methods.9,34,35 Data were expressed as a mean ± SD or SEM, or median and 
range. Student’s t test was used for the statistical analyses, unless otherwise noted, with a 
significance threshold of P < 0.05.
RESULTS
Study Populations
The CUNV cohort consisted of 9 consecutive patients (4 diabetic), with median 4-hour 
gastric retention of 4% (range 2 – 9%) and median total symptom score of 16/20 (range 9.5–
20). The mean time from gastric emptying test to surgery was 2.1 ± 2.3 months. The HR 
mapping controls also consisted of 9 patients, of comparable age to the CUNV cohort 
(P=0.14). Table 1 compares the CUNV and HR mapping control populations, with 
individual patient data provided in Supplementary Tables 1 and 2. The ICC control cohort 
was appropriately age-matched to the CUNV cohort (paired mean difference 0.3 years; 
P=0.8).
ICC Density and Ultrastructural Analysis
Tissue specimens were obtained from 7/9 CUNV patients. Figure 2 shows representative 
images comparing ICC density and ultrastructural features between CUNV patients and 
controls. Overall, average ICC density was reduced in CUNV patients compared to controls 
(mean 3.5 ± 0.3 SEM vs 5.6 ± 0.5 cell bodies/field; P<0.05; Figure 3). There was no 
difference between ICC densities from CUNV patients with diabetes versus without (P=0.9). 
Individual ICC densities for the CUNV patients are reported in Supplementary Table 1 
(range: 2.8 – 4.7 cell bodies/field).
The results for ICC density in CUNV patients were then compared with the historical 
gastroparetic cohort (mean 2.3 ± 0.3 SEM bodies/field), collected and analyzed using 
identical protocols.9 A one-way ANOVA between the CUNV, gastroparesis, and combined-
control cohorts showed that ICC density differed significantly across the three groups 
(P<0.05). A Newman-Keuls post-hoc comparison between the three groups indicated that 
the combined controls had higher ICC density than the CUNV (P<0.05; mean difference: 
2.0 bodies/field) and gastroparesis (P<0.05; mean difference: 3.2 bodies/field) cohorts. In 
addition, ICC density was higher in the CUNV than gastroparesis cohort (P<0.05; mean 
difference: 1.2 bodies/field; Figure 3).
Ultrastructural analyses revealed abnormalities in the ICC of 5/7 sampled CUNV patients 
compared to matched controls (Figure 2C,D). These abnormalities were less severe than 
those previously reported in gastroparesis,8 primarily consisting of thickened basal lamina, 
particularly near nerve endings, smooth muscle cells, and nerve fibers, as well as scattered 
cytoplasmic anomalies including lamellar bodies, dilated reticulum, vacuoles, and myelin 
bodies (Figure 2C).
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Controls—A total of 11 recordings were performed on the 9 controls at the mid-to-lower 
gastric corpus and antrum (Figure 1), with a mean recording duration of 10 ± 3 SD min/
patient. The mean slow wave frequency across the control cohort was 2.7 ± 0.1 SEM cycles/
min. In 8/9 patients, entirely normal gastric activation patterns were observed; slow wave 
activity propagated exclusively in the antegrade direction with wavefronts oriented 
orthogonal to the curvatures (Figure 1). In these 8 controls, all activity was consistent with 
the established single pacemaker system of the normal human stomach (mean corpus 
velocity 3.0 ± 0.3 SEM mm/s).22
In one control (ID #4 in Supplementary Table 2), dysrhythmic slow wave activity was 
observed. At the time of mapping this patient, it was noted that the stomach was 
significantly distended with air following pre-oxygenation and intubation. This dysrhythmia 
occurred as a stable ectopic pacemaker in the mid-corpus, was present at the onset of 
mapping, and persistent for 330 seconds before becoming entrained by normal antegrade 
activity (Supplementary Figure 1).
CUNV Patients—A total of 18 recordings were performed on the corpus and antrum of the 
9 CUNV patients, with a mean duration of 11 ± 5 SD min/patient, which was comparable to 
the control recordings (P = 0.7). Dysrhythmic slow wave activity was observed in all 9/9 
patients, and the observed dysrhythmias were classified as abnormalities of initiation (8/18 
recordings; 6/9 patients) or abnormalities of conduction (11/18 recordings; 8/9 patients). 
Abnormalities of initiation and conduction coexisted in 5/9 patients. These dysrhythmic 
patterns were further classified according to the schema summarized in Figure 4.
Across all CUNV patients, the mean frequency during dysrhythmic slow wave activity was 
3.3 ± 0.3 SEM cycles/min (range 2.0 – 5.1 cycles/min), which was similar to that of controls 
(P > 0.05). Dysrhythmias occurred at normal frequency in 5/9 patients, bradygastric 
frequency (<2.4 cycles/min) in 2/9 patients, and tachygastric frequency (>3.7 cycles/min) in 
2/9 patients.
Slow wave activity propagated at a mean longitudinal velocity of 3.3 ± 0.6 SEM mm/s in the 
dysrhythmic CUNV cohort, which was similar to that in controls (P = 0.7). Circumferential 
propagation was also routinely observed during dysrhythmia and exhibited a highly 
anisotropic velocity profile, whereby propagation occurred more rapidly in the 
circumferential direction (mean 7.6 ± 1.5 SEM mm/s) than the longitudinal direction (P < 
0.01). During longitudinal propagation, the extracellular slow wave amplitudes were 
comparable between CUNV patients and controls (mean 0.30 ± 0.08 SEM vs 0.33 ± 0.05 
mV; P = 0.7).
Abnormalities of Slow Wave Initiation—Abnormal initiation of slow wave activity 
was identified in 8/18 recordings from 6/9 patients (Figure 5 and Supplementary Figure 2), 
whereby slow wave activity was initiated from a location other than the normal gastric 
pacemaker region (greater curvature, mid-to-upper corpus22). These abnormalities of 
initiation were further classified as either stable (occurring consistently in the same location 
over time) or unstable (transient focal activities occurring in variable locations). Stable 
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ectopic initiation (ectopic pacemaking; e.g., Supplementary Figure 2) was the most 
prevalent abnormality of initiation, observed in 4 patients, and occurring for a mean 
captured duration of 109 ± 42 SD s, although all instances were either present at the 
beginning, or persistent through the end, of the recording period. Unstable ectopic focal 
activities were observed in 2 patients, and lasted for only 18 s (1 cycle) and 50 s (2 cycles; 
Figure 5C, D), respectively.
Abnormal slow-wave initiation occurred at mean frequency of 3.1 ± 0.5 SEM cycles/min 
(range 2.0 – 5.1 cycles/min), with individual ectopic events occurring at bradygastric (1 
stable; 1 unstable), normal (3 stable), and tachygastric (1 unstable) frequencies. One patient 
(Figure 5; ID #2, Supplementary Table 1) displayed unstable focal activity for two cycles at 
bradygastric frequency (mean 2.0 ± 0.1 SD cycles/min; Figure 5C, D), which was then 
entrained by a new stable ectopic pacemaker occurring at a normal frequency (mean 3.2 ± 
0.2 SD cycles/min; Figure 5E, F) that continued to the end of the recording period.
Ectopic slow wave initiation was always associated with disorganized slow wave 
propagation. These patterns were characterized as secondary abnormalities of conduction 
and are described in the following section.
A third abnormality of slow wave initiation was observed in three recordings from a single 
patient (ID #1, Supplementary Table 1), whereby a complete lack of slow wave initiation 
and activity occurred across the entire mapped field of all three consecutive recordings. The 
electrode signals from these recordings exhibited stable baseline activity with low noise, and 
cardiac signal complexes were clearly distinguishable under modified filtering parameters 
(Supplementary Figure 3), indicating that the electrodes were functioning and that 
satisfactory contact with the serosal surface had been achieved.
Abnormalities of Slow Wave Conduction—Abnormalities of slow wave conduction 
occurred in 11/18 recordings in 8/9 patients and included conduction blocks, re-entrant 
activity, retrograde propagation, and colliding wavefronts.
Conduction blocks occurred in 4/9 patients, whereby slow wave activation terminated 
abnormally. In one case (Figure 5), a complete conduction block manifested between 
uncoupled slow wave activation propagating in opposite directions, where the block 
extended the entire width of the mapped area. In the other three cases of observed 
conduction blocks, the blocks were incomplete, inducing a wavelet that subsequently excited 
the tissue region distal to the block (e.g., Supplementary Figure 4).
Re-entrant slow wave activity occurred in a single patient, whereby wavefronts propagated 
in a complete loop around a line of unidirectional block, continuously re-activating the same 
tissue circuit over successive cycles (Figure 6). Wavefronts emanated outward from the site 
of re-entry (mean frequency 3.3 ± 0.2 SD cycles/min), establishing propagation in all 
directions and resulting in wavefront collisions with antegrade-propagating wavefronts. In 
addition, there was one further case of conduction block with looping propagation pattern 
that was incompletely captured by the mapped field, and was therefore classified as being of 
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indeterminate origin. This dysrhythmia operated at a tachygastric frequency (mean 4.3 ± 0.3 
SD cycles/min).
In general, disorganized slow wave propagation occurred secondary to all of the previously 
described abnormalities of initiation and conduction, and was quantified as retrograde 
propagation and wavefront collisions. Retrograde propagation occurred in 10/18 recordings 
across 8/9 patients, originating from ectopic pacemakers (5 recordings), sites of re-entry (1 
recording), and unidentified sites outside the mapped field (4 recordings). Retrograde 
propagation occurred at a mean velocity of 3.3 ± 0.7 SEM mm/s, which was comparable to 
that of antegrade propagation in controls (mean 3.0 ± 0.3 SEM mm/s; P = 0.7) and CUNV 
(mean 3.3 ± 0.6 SEM mm/s; P = 0.9), demonstrating directional velocity isotropy in the 
longitudinal axis of the human stomach.
Wavefront collisions occurred in 7/18 recordings across 5/9 patients, where a retrograde or 
circumferentially-propagating wavefront collided with opposing propagation (e.g., Figures 5 
and 6, and Supplementary Figure 2). Wavefront collisions were associated with wavefronts 
originating from ectopic pacemakers (4 recordings; e.g., Figure 5 and Supplementary Figure 
2), unidentified sources located outside of the mapped field (2 recordings), and re-entry (1 
recording; Figure 6).
Normal Slow Wave Propagation—Although all CUNV patients exhibited some form of 
dysrhythmic activity during at least one of their recording periods, a subset of 4/18 
recordings from 3/9 patients displayed a normal slow wave propagation pattern for the entire 
recorded duration. This normal propagation occurred at a mean frequency of 2.8 ± 0.2 SEM 
cycles/min (range 2.4 – 3.2 cycles/min) and propagated at a mean longitudinal velocity of 
2.8 ± 0.6 SEM mm/s, both of which were similar to that of controls (P = 0.8 and 0.6, 
respectively).
DISCUSSION
CUNV is accompanied by considerable morbidity, but has remained a poorly characterized 
disorder of unknown etiology. This study quantified ICC numbers and ultrastructural 
features, in combination with modern slow wave mapping techniques,12 to investigate 
pathogenic mechanisms contributing to CUNV. It was found that CUNV patients had ICC 
depletion and abnormal slow wave initiation and conduction, compared to controls. Further 
comparison to a historic cohort of gastroparetic patients9 revealed that ICC depletion and 
ultrastructural abnormalities were less severe in CUNV than in gastroparesis, but 
abnormalities of slow wave initiation and conduction were similar. The cellular and 
electrophysiological abnormalities observed in this study offer plausible contributing 
mechanisms to the pathophysiology of CUNV.
This study was partly motivated by a recent report by Pasricha et al., which provided the 
first comprehensive account of the demographic and clinical features of CUNV.2 CUNV 
was shown to be clinically indistinguishable from gastroparesis over a one-year follow-up 
period, which is consistent with other literature.3,4 Pasricha et al. concluded that further 
research was needed to conclusively determine whether CUNV is part of a spectrum of the 
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same syndrome as gastroparesis, or represents a distinct disorder(s).2 Both conclusions may 
hold truth as CUNV is likely heterogeneous. However, our study does support the idea that 
CUNV may, at least in part, be encompassed within the same disease spectrum as 
gastroparesis, by demonstrating that these disorders share common cellular and bioelectrical 
pathophysiologies.7,9 Of note, the ICC depletion and ultrastructural abnormalities in the 
CUNV cohort were less marked than in previous gastroparesis cohorts analyzed by 
equivalent methods,8,9 and the actual ICC densities are consistent with a previous 
observation that depletion of less than 3 ICC bodies per field may represent a threshold 
below which failure of gastric emptying becomes more likely.19 Gastric distension has been 
ruled out as a confounding factor in ICC counts using comparative smooth muscle nuclei 
counts.9
We focused on ICC because they are the predominant cellular abnormality in gastroparesis,7 
and because ICC densities correlate with gastric emptying, unlike other markers.21 
However, ICC, neuronal, and smooth muscle pathologies often co-exist, perhaps due to 
cellular interdependence, and it is not always clear which changes hold primacy.36 Other 
histologic abnormalities described in gastroparesis include an immune cell infiltrate typified 
by CD45 and CD68 immunoreactivity, decreased nerve fibres,7 and ultrastructural 
degradation of remaining ICC.8 These factors were not a focus of the present study, but 
would be of interest in future studies of CUNV.
The HR mapping outcomes reported in this study corroborate and expand the known range 
of dysrhythmic human slow wave patterns. These patterns have been accurately assessed in 
only one previous study in gastroparetic patients,9 of which the results of the present study 
are consistent. CUNV and gastroparesis both showed heterogeneous patterns of abnormal 
initiation and conduction, including stable and unstable ectopic pacemaking, conduction 
blocks, and secondary propagation abnormalities of retrograde propagation and colliding 
wavefronts. It was also shown that human gastric dysrhythmias routinely occurred within a 
frequency range considered normal, while normal activity could occur at frequencies 
sometimes considered abnormal, challenging ‘normal’ frequency conceptions.31 These 
results validate and reinforce that spatial mapping enables a substantially more accurate 
method of dysrhythmia detection than classical electrogastrography, which mainly focused 
on frequency31 and therefore likely underestimated the occurrence of slow wave 
abnormalities. The results from the present study also facilitate an updated classification 
schema for human gastric dysrhythmias, focused on spatial pattern.9 Furthermore, the 
finding that a subset of 4/18 recordings exhibited normal activity demonstrated that multiple 
recordings, or at least sustained recordings of greater than about five minutes, may be 
necessary to consistently detect dysrhythmic activity.
This study described re-entrant slow wave activity in the human gut. Originally described by 
Lammers et al. in 2008 in a canine model,37 and subsequently in several other invitro and 
in-vivo animal models,34,35,38 re-entry is now a focus of considerable recent interest as a 
mechanism of sustained gastrointestinal dysrhythmias.39 Based on our findings, re-entry is a 
relatively uncommon dysrhythmia in the human stomach, likely because there is a narrow 
excitable gap, or window, in which an aberrant stimulus can successfully invoke a re-entry, 
based on the relative timing of the leading depolarizing edge and refractory tail.34,35,39 Re-
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entry is also an important finding because it is a potentially treatable form of dysrhythmia, 
for example, by gastric pacing guided by mapping,40 as is routinely achieved in cardiology.
The fact that CUNV patients had normal gastric emptying despite pronounced dysrhythmia 
is consistent with previous literature, which has shown an overall positive predictive value 
of EGG abnormalities for abnormal gastric emptying of only ~65%.31 Significantly, gastric 
emptying shows no correlation with nausea and vomiting, while dysrhythmia shows 
consistent correlations with these symptoms across multiple disease states.2,13 It is therefore 
evident that the stomach has compensatory mechanisms that may preserve emptying despite 
dysrhythmias, including the rapid circumferential conduction evident in this study, which 
may aid in restoring propulsive ring contractions distal to dysrhythmic events.9,33 Together 
with dysrhythmias, other ICC abnormalities occurring in gastroparesis could cumulatively 
be contributing to delayed emptying. For example, residual ICC in gastroparesis show 
marked cellular damage, and may generate a reduced volume of current to excite smooth 
muscle.8,9,13 ICC roles in modulating resting membrane gradients, neurotransmission, and 
mechanotransduction could also be significant, but more research is needed. The presence of 
a thickened basal lamina at the contact between ICC and nerve endings in CUNV patients is 
suggestive of impairment in the crosstalk, which in turn could influence the ICC rhythmic 
activity. Further studies are now required to investigate mechanisms by which ICC damage 
causes dysrhythmia, and how dysrhythmia causes nausea and vomiting, with current 
evidence suggesting such causal associations are plausible.13
One control subject exhibited dysrhythmic slow wave activity, characterized by tachygastric 
ectopic pacemaking in the mid-corpus. This represents the only instance of slow wave 
dysrhythmia in 21 normal controls mapped to date (9 in this study, 12 in a previous study22), 
and may have occurred due to excessive gastric distension in this patient following 
anesthetic induction and intubation. A similar type of dysrhythmic initiation has previously 
been described with antral balloon distension in healthy humans.41 It may prove necessary 
to exclude subjects showing gastric distension in future studies. It is also possible that 
normal subjects have episodes of self-correcting dysrhythmia. The research implication of 
this dysrhythmic finding in a control patient was that it provided an opportunity to quantify 
circumferential conduction parameters in the healthy human stomach. The observed 
conduction profile in this patient exhibited velocity anisotropy similar to that observed in the 
ICC-depleted CUNV cohort, and also previously observed in animals and ICC-depleted 
gastroparetic humans.9,33
The main limitation of this study was the relatively small sample size. However, the current 
limited cohort is unique because intraoperative access is rare in CUNV patients, and the 
operative gastric stimulator implantation that allowed surgical access for this study is 
usually only offered for gastroparesis. Furthermore, this study also required the recruitment 
of intra-operative mapping controls. Because the mapping in this study required surgical 
access, it was performed in the anesthetized state; it would be desirable to investigate these 
slow wave patterns in awake, fed, and fasted patients, when future technological advances 
allow. While we chose the definition ‘CUNV’ following Pasricha et al.,2 such nomenclature 
is not standardized. Alternative terms have included ‘gastroparesis-like syndrome’ and 
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‘vomiting of unexplained etiology’, while the Rome III system introduced ‘chronic 
idiopathic nausea’ and ‘functional vomiting’ within more restrictive scopes.
Methodological advances will be necessary to apply these findings to clinical diagnostics in 
future, in order to reduce the invasiveness of current gastric HR mapping methods. 
Significant technical hurdles must be overcome, including endoscopic device development, 
reliable methods of automated real-time data analysis, and cost reductions in acquisition 
equipment.12,13 In addition, therapeutic trials will ultimately be required, to assess whether 
gastric dysrhythmias can be reversed in a way that meaningfully improves symptoms and 
quality of life in affected patients.
In conclusion, ICC and bioelectrical abnormalities were found in CUNV patients, similar to 
changes occurring in gastroparesis. These findings offer new pathogenic mechanisms 
underlying CUNV, and may inform future therapies.
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Normal gastric slow wave propagation in a control. (A) Position of the array. (B) 
Electrograms from positions indicated in C (frequency, 2.8 ± 0.1 SD cycles/min). (C) 
Isochronal activation map of ‘Wave 1’ indicated in B, demonstrating normal antegrade 
propagation. Black dots represent electrodes, with white dots outlined red representing 
electrodes where activity was interpolated. Each color band shows the area of slow wave 
propagation per 2 seconds. (D) Velocity map of Wave 1, showing the speed (color 
spectrum) and direction (arrows) of the wavefront at each electrode. (E,F) Isochronal 
activation and velocity field maps of ‘Wave 2’ in B, demonstrating consistency of the 
antegrade propagation. See Supplementary Video 1 for animation.
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(A,B) Representative images showing depletion of the ICC network in the gastric smooth 
muscle in a CUNV patient (A) compared to control (B). The red signal is Kit 
immunoreactivity marking ICC; the blue signal is 4’,6’-diamidino-2-phenylindone 
counterstain marking cellular nuclei. (C,D) Electron microscopy images showing mild 
ultrastructural abnormalities in a CUNV patient (C) compared to control (D). Labeled 
structural components: thick basal lamina (small astericks), nerve endings (NE), smooth 
muscle cells (SMC), lamellar body (LB), ICC-SMC contact (arrows), and peg-and-socket 
junction (large astericks).
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Comparison of ICC density between CUNV patients and healthy controls. Data from a 
recent gastroparesis (GP) cohort9 (in grey) are also displayed for comparison.
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Classification and occurrence of slow wave dysrhythmias mapped in CUNV patients. ‘N’ 
signifies normal frequency. There was one additional case (ID #5) of tachygastria of 
indeterminate origin, and a further case (ID #1) of apparent slow wave quiescence (see text).
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Abnormal slow wave initiation and conduction; isochronal intervals = 1.5 seconds. (A) 
Position of the array. (B) Representative electrograms from positions indicated in C; 
propagation sequences are labeled based on their corresponding waves 1–4, shown in panels 
C–F. (C) Isochronal activation map. Slow wave activity propagated onto the array from the 
greater-curvature, colliding with an unstable focal activity on the distal portion of the array. 
(D) The unstable focal activity was consistent over a second cycle. (E) A new stable ectopic 
pacemaker emerged in the distal portion of the array (represented by a star), initiating 
retrograde propagation that collided with the uncoupled antegrade wavefront. 
Circumferential propagation was out-of-phase with distal activity that was propagating in 
the opposite direction circumferentially, resulting in a complete functional conduction block 
(thick black line). (F) Propagation repeated as described in E, with stability of the ectopic 
pacemaker and distal block that remained consistent through the end of the recording period. 
A frequency increase occurred between the unstable focal activity of C&D (bradygastric, 2.0 
± 0.1 cycles/min) and the stable ectopic activity of E&F (normal frequency, 3.2 ± 0.2 
cycles/min). See Supplementary Video 2 for animation.
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Slow wave re-entry; isochronal intervals = 2 seconds. (A) Position of the array. (B) 
Representative electrograms from positions indicated in C; electrode 1 is repeated at the 
bottom of the electrograms to illustrate the continuity of the re-entrant circuit. (C–E) 
Isochronal activation maps. Activation propagated in a circuit around a linear conduction 
block (thick black line), re-activating that same circuit over successive cycles, thereby 
establishing re-entry (frequency, 3.3 ± 0.2 cycles/min). Slow wave activity propagated 
outward from the re-entrant circuit, in part colliding with an uncoupled antegrade-
propagating wavefront. See Supplementary Video 3 for animation.
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Table 1
Comparison of characteristics between the CUNV population and mapping controls. Methods of mapping and 
data analysis were identical.
Characteristic CUNV cohort Control cohort
No. of patients 9 9
Median age, y (range) 50 (22–59)* 57 (25–74)*
Sex (female:male) 8:1 5:4
No. of recordings 18 11
Duration of mapping (mean ± SD) 11 ± 5 min/pt 10 ± 3 min/pt
Anesthetic regimen Prophylactic antibiotics, benzodiazepine 
premedication, a short-acting intravenous 
opiate, muscle relaxants (suxamethonium or 
rocuronium), propofol, desflurane
Prophylactic antibiotics, benzodiazepine 
premedication, a short-acting intravenous opiate, 
muscle relaxant (atracurium or suxamethonium), 
propofol, isoflurane, or sevoflurane. Eight also had 
epidural or spinal block.
Electrodes (type; tip diameter; no. of 
channels)
PCB24; 0.3 mm; 256 channels PCB24; 0.3 mm; 96–256 channels
Filtering methods Savitzky-Golay (1.7s window; polynomial order 9) and moving median (20s window) filters28
Analysis and isochronal activation 
mapping methods
FEVT, REGROUPS, and SIV algorithms performed in GEMS v1.5 with subsequent manual 
review27,29,30
Frequency, velocity, and amplitude 
calculation methods
Algorithms in GEMS v1.527
*
P = 0.14.
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